KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Depreciation and Depletion: 2009-2025

Historic Depreciation and Depletion for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $227.0 million.

  • Thermo Fisher Scientific's Depreciation and Depletion fell 21.99% to $227.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 5.76%. This contributed to the annual value of $1.2 billion for FY2024, which is 8.24% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Depreciation and Depletion stood at $227.0 million, which was down 11.33% from $256.0 million recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Depreciation and Depletion ranged from a high of $304.0 million in Q4 2024 and a low of $198.0 million during Q2 2021.
  • Its 3-year average for Depreciation and Depletion is $271.2 million, with a median of $276.0 million in 2025.
  • In the last 5 years, Thermo Fisher Scientific's Depreciation and Depletion soared by 34.39% in 2021 and then dropped by 21.99% in 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Depreciation and Depletion (Quarterly) stood at $217.0 million in 2021, then increased by 17.97% to $256.0 million in 2022, then climbed by 7.81% to $276.0 million in 2023, then grew by 10.14% to $304.0 million in 2024, then declined by 21.99% to $227.0 million in 2025.
  • Its Depreciation and Depletion was $227.0 million in Q3 2025, compared to $256.0 million in Q2 2025 and $276.0 million in Q1 2025.